The National Rosacea Society’s updated Rosacea Treatment Algorithms provide a comprehensive summary of therapeutic options for each phenotype of rosacea.

The new version is organized according to the phenotype model established by the 2017 updated standard classification and pathophysiology of rosacea. It suggests therapeutic approaches to mild, moderate, and severe presentations of each phenotype based on the 2019 update to the standard management options for rosacea, as well as the original management options and studies of more recently developed therapies.

Diagnostic Signs of Rosacea

According to the updated standard classification of rosacea, the presence of persistent facial redness or, less commonly, phymatous changes, is considered diagnostic of the disorder. Additional major signs, which often appear with the diagnostic features, include papules and pustules, flushing, telangiectasia, and certain ocular manifestations. The presence of two or more major features independent of the diagnostic signs is also considered diagnostic of rosacea, and secondary signs and symptoms include burning or stinging, swelling, and dry appearance.

The new targeted approach encourages consideration of the full range of potential signs and symptoms, better assessment of their severity, and selection of treatment that is more precisely tailored for each individual case.